Market and company headlines
By Brad Sorensen, CFA OTCQB: PBSV READ THE FULL PBSV RESEARCH REPORT Pharma-Bio Serv, Inc. (OTCQB: PBSV) is beginning to show the benefits of the operational changes management has been implementing over the past several quarters. The company’s fiscal third-quarter results provide additional evidence that the strategy of concentrating resources on higher-value markets, improving operating
Yahoo·07:09·Last MonthPBSV
DORADO, PR / ACCESS Newswire / September 14, 2026 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm today announced that revenues for the three and nine months ended July 31, 2026 were approximately $2.
Yahoo·17:20PBSV